# Safety and Efficacy of OCL 503 in Prostate Artery Embolization

> **NCT02509975** · NA · COMPLETED · sponsor: **IMBiotechnologies Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Benign Prostatic Hypertrophy

## Interventions

- **DEVICE:** Prostate artery embolization.

## Key facts

- **NCT ID:** NCT02509975
- **Lead sponsor:** IMBiotechnologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02509975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02509975, "Safety and Efficacy of OCL 503 in Prostate Artery Embolization". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02509975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*